Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole

Detalles Bibliográficos
Autores principales: Crosby, L. D., Kalanidhi, S., Bonilla, A., Subramanian, A., Ballon, J. S., Bonilla, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860172/
https://www.ncbi.nlm.nih.gov/pubmed/33536023
http://dx.doi.org/10.1186/s12967-021-02721-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860172/
https://www.ncbi.nlm.nih.gov/pubmed/33536023
http://dx.doi.org/10.1186/s12967-021-02721-9

Ejemplares similares